Literature DB >> 10561699

Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations.

D H Gutmann1, C A Haipek, K Hoang Lu.   

Abstract

The neurofibromatosis 2 (NF2) tumor suppressor gene product, merlin (schwannomin) forms an intramolecular association that is required for negative growth regulation in vitro and in vivo. In an effort to develop a molecular model for merlin relevant to its tumor suppressor function, we further characterized merlin intramolecular folding. We now demonstrate that merlin forms two intramolecular associations, one between the amino terminal (N-term) domain and the carboxyl terminal (C-term) domain and another within the amino terminal domain (N-term/N-term) itself. The N-term/C-term domain interaction requires contact between residues 302-308 in the N-term and an intact exon 17 (residues 580-595) in the C-term domain. In addition, we demonstrate that the N-term/N-term domain self-interaction is required for N-term/C-term domain association. Lastly, we identify NF2 patient mutations that dramatically reduce each of these interactions in vitro. Based on these findings, we propose a model for merlin folding critical to its ability to function as a tumor suppressor protein. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561699

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

1.  Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.

Authors:  Minja Laulajainen; Taru Muranen; Tuula A Nyman; Olli Carpén; Mikaela Grönholm
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

2.  Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.

Authors:  Rong Rong; Xiaoling Tang; David H Gutmann; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-14       Impact factor: 11.205

Review 3.  The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

Authors:  M E Baser; L Kuramoto; R Woods; H Joe; J M Friedman; A J Wallace; R T Ramsden; S Olschwang; E Bijlsma; M Kalamarides; L Papi; R Kato; J Carroll; C Lázaro; F Joncourt; D M Parry; G A Rouleau; D G R Evans
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

4.  Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.

Authors:  Iram Ahmad; Augusta Fernando; Richard Gurgel; J Jason Clark; Linjing Xu; Marlan R Hansen
Journal:  Neurobiol Dis       Date:  2015-06-06       Impact factor: 5.996

5.  Loss of NF2/Merlin expression in advanced sporadic colorectal cancer.

Authors:  Tamara Cačev; Gorana Aralica; Božo Lončar; Sanja Kapitanović
Journal:  Cell Oncol (Dordr)       Date:  2013-12-10       Impact factor: 6.730

Review 6.  Molecular insights into NF2/Merlin tumor suppressor function.

Authors:  Jonathan Cooper; Filippo G Giancotti
Journal:  FEBS Lett       Date:  2014-04-12       Impact factor: 4.124

7.  Mouse models of neurofibromatosis 1 and 2.

Authors:  David H Gutmann; Marco Giovannini
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

8.  Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.

Authors:  Kseniya Golovnina; Alexander Blinov; Elena M Akhmametyeva; Leonid V Omelyanchuk; Long-Sheng Chang
Journal:  BMC Evol Biol       Date:  2005-12-02       Impact factor: 3.260

9.  Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.

Authors:  Caisa M Hansson; Patrick G Buckley; Giedre Grigelioniene; Arkadiusz Piotrowski; Anders R Hellström; Kiran Mantripragada; Caroline Jarbo; Tiit Mathiesen; Jan P Dumanski
Journal:  BMC Genomics       Date:  2007-01-12       Impact factor: 3.969

10.  Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with β1 integrin and actin at the plasma membrane.

Authors:  Maria Elisa Manetti; Sandra Geden; Marga Bott; Nicklaus Sparrow; Stephen Lambert; Cristina Fernandez-Valle
Journal:  Biol Open       Date:  2012-08-02       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.